2014•Practical Journal of Cardiac Cerebral Pneumal and Vascular DiseaseRequires access

Effect of Duloxetine Combined with Cognitive Therapy on Persistent Somatoform Pain Disorder

Wang De-su

Open publisher page 0 citations

Abstract

Objective To observe the effect of duloxetine combined with cognitive therapy on persistent somatoform pain disorder( PSPD). Methods 70 patients with PSPD admitted to our hospital from August 2012 to March 2013 were randomly divided into groups study and control. Both groups were given duloxetine,starting dose was 30 mg / d; study group was given cognitive therapy on the basis of control group. The pain effect was evaluated by pain scale( MOSPE) after 6 weeks treatment. Both were applied Hamilton depression scale( HAMD) before and 2,4,6 weeks after treatment. Results The efficacy of groups study and control was 82. 9%(29 /35) and 77. 1%(27 /35). There was no satistically significant difference in efficacy between two groups( χ2= 0. 36,P 0. 05). HAMD score of study group was lower than that of control group 4,6 weeks after treatment( P 0. 05). Conclusion Duloxetine has better effect and tolerance on PSPD,and is helpful to improve the depressive symptoms when combined with cognitive therapy.

About this research paper

What this paper is about

Objective To observe the effect of duloxetine combined with cognitive therapy on persistent somatoform pain disorder( PSPD). Methods 70 patients with PSPD admitted to our hospital from August 2012 to March 2013 were randomly divided into groups study and control. Both groups were given duloxetine,starting dose was 30 mg / d; study group was given cognitive therapy on the basis of control group. The pain effect was evaluated by pain scale( MOSPE) after 6 weeks treatment. Both were applied Hamilton depression scale( HAMD) before and 2,4,6 weeks after treatment. Results The efficacy of groups study and control was 82. 9%(29 /35) and 77. 1%(27 /35). There was no satistically significant difference in efficacy between two groups( χ2= 0. 36,P 0. 05). HAMD score of study group was lower than that of control group 4,6 weeks after treatment( P 0. 05). Conclusion Duloxetine has better effect and tolerance on PSPD,and is helpful to improve the depressive symptoms when combined with cognitive therapy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effect of duloxetine combined with cognitive therapy on persistent somatoform pain disorder( PSPD). Methods 70 patients with PSPD admitted to our hospital from August 2012 to March 2013 were randomly divided into groups study and control. Both groups were given duloxetine,starting dose was 30 mg / d; study group was given cognitive therapy on the basis of control group. The pain effect was evaluated by pain scale( MOSPE) after 6 weeks treatment. Both were applied Hamilton depression scale( HAMD) before and 2,4,6 weeks after treatment. Results The efficacy of groups study and control was 82. 9%(29 /35) and 77. 1%(27 /35). There was no satistically significant difference in efficacy between two groups( χ2= 0. 36,P 0. 05). HAMD score of study group was lower than that of control group 4,6 weeks after treatment( P 0. 05). Conclusion Duloxetine has better effect and tolerance on PSPD,and is helpful to improve the depressive symptoms when combined with cognitive therapy.

Key concepts: Duloxetine, Medicine, Hamd, Hamilton depression scale, Depression (economics), Internal medicine, Significant difference, Alternative medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of Duloxetine Combined with Cognitive Therapy on Persistent Somatoform Pain Disorder — Research Paper | ScholarLens